Takaisin kurssilistaukseen

Prevention of HPV-associated oropharyngeal squamous cell cancer (OPSCC)

Kurssin aikataulu

  • 09:00

    Epidemiology of OPSCC

  • 09:00

    Word-wide occurrence of oropharyngeal cancer

    Dr. Iacopo Baussano International Agency for Research on Cancer (IARC)

  • 09:30

    Oropharyngeal cancer trends in the Nordic countries

    Dr. Tuomas Lehtinen FICAN-Mid

  • 10:00

    Familial occurrence of OPSCC and other HPV-associated cancers

    Dr. Kari Hemminki Deutsches Krebsforschungszentrum (DKFZ)

  • 10:30

    Tauko

  • 11:00

    Biological basis and means of OPSCC elimination

  • 11:00

    The relative role of HPV in oropharyngeal cancer

    Dr. Massimo Tommasino IARC

  • 11:30

    Efficacy of vaccination against oropharyngeal HPV infection

  • 12:00

    Tauko

  • 13:00

    Screening of HPV-associated OPSCC – the Hamburg trial

    Dr. Michael Pawlita DKFZ

  • 13:30

    Risk-stratified screening of OPSCC – the Finnish trial

    Dr. Matti Lehtinen THL

  • 14:00

    Tauko

  • 14:30

    Cost-effectiveness of OPSCC elimination

  • 14:30

    Management of HPV-positive and HPV-negative OPSCC

    Dr. Antti Mäkitie University of Helsinki

  • 15:00

    Cost-effectiveness of eliminating HPV-associated OPSCC

    Dr. Simopekka Vänskä Finnish Institute for Health and Welfare (THL)

  • 15:30

    Eradication of oncogenic HPV types – the ultimate goal

    Dr. Joakim Dillner Karolinska Institute

Matti Lehtinen, FICAN-Mid, THL and Antti Mäkitie, FICAN-South, University of Helsinki
Kurssinumero: 104
Paikka: Sali 206
Aika: 8.1.2020 09:00 - 16:00
Aihealueet: Tutkijoille
Puheenjohtaja: Dr., Matti Lehtinen , Finnish Cancer Center Mid (FICAN-Mid), THL
Dr., Antti Mäkitie , University of Helsinki
Dr., Eero Pukkala , University of Tampere
Yhdyshenkilö: Dr., Matti Lehtinen , Finnish Cancer Center Mid (FICAN-Mid), THL
Tavoite:
Kohderyhmä: